Table 4 Survival of patients with aortic valve replacement

From: Surgical and transcatheter aortic valve replacement after orthotopic heart transplantation: a case series

Parameter

All (N = 16)

TAVR (N = 9)

SAVR (N = 7)

Survival time after valve surgery (years)

1.5 (0.9; 2.6)

1.2 (0.3; 2.4)

1.5 (1.3; 2.7)

Survival time after HTX (years)

17 (11; 19)

18 (16; 18)

12 (8; 19)

All-cause Mortality

Peri-procedural ( ≤ 30 days)

0 (0%)

0 (0%)

0 (0%)

Early ( > 30 days and ≤ 1 year)

3 (19%)

3 (33%)

0 (0%)

Late ( > 1 year and ≤ 3 years)

6 (60%)

2 (50%)

4 (67%)

Censored ≤ 90 days

1 (6%)

0 (0%)

1 (14%)

Censored > 1 year and <3 years

3 (19%)

2 (22%)

1 (14%)

Cardiovascular mortality (at 1 year)

0 (0%)

0 (0%)

0 (0%)

Cardiovascular mortality ( > 1 year)

acute graft failure

2 (13%)

0 (0%)

2 (33%)

valve-related mortality

0 (0%)

0 (0%)

0 (0%)

Cause of death

Graft failure/rejection

3 (27%)

0 (0%)

3 (50%)

Sepsis/infection

5 (46%)

4 (80%)

1 (17%)

Unknown

3 (27%)

1 (20%)

2 (33%)

  1. Categorical data is displayed as numbers (%), continuous data is stated as median (interquartile range).
  2. HTX heart transplantation, TAVR transcatheter aortic valve replacement, SAVR surgical aortic valve replacement, NAR number at risk.